erdafitinib for bladder cancer: more to come following fda approval
Published 4 years ago • 402 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
2:20
the role of erdafitinib in treating patients with bladder cancer
-
1:27
erdafitinib and enfortumab vedotin in pretreated fgfr2/3-mutant bladder cancer
-
1:49
blc2001: erdafitinib for the treatment of metastatic urothelial carcinoma
-
0:55
targeted therapy option of erdafitinib in bladder cancer #oncology #cancer #2023
-
2:12
erdafitinib: one more tool for bladder cancer
-
2:31
an update on erdafitinib for metastatic/uresectable fgfr alteration urothelial carcinoma
-
1:47
thor: erdafitinib in metastatic urothelial cancer with fgfr alterations
-
4:43
erdafitinib for fgfr-mutated urothelial carcinoma
-
1:47
the future role of erdafitinib in advanced urothelial carcinoma
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
2:20
erdafitinib /- cetrelimab in muc patients with fgfr alterations
-
2:52
fgfri treatment-emergent aes in urothelial cancer
-
1:04
thor: erdafitinib in advanced or metastatic urothelial cancer and fgfr alterations
-
3:42
norse: erdafitinib cetrelimab in muc with fgfr alterations
-
0:34
pembrolizumab plus enfortumab vedotin for bladder cancer
-
1:13
bladder cancer
-
2:02
the evolving treatment landscape for urothelial cancer
-
1:47
dr. sonpavde on the safety profile of erdafitinib in bladder cancer
-
1:58
enfortumab vedotin for the treatment of advanced urothelial cancer